CTSN PACES (A-Fib)

Purpose of this Study

We are doing this research to learn more about whether taking a blood thinner, along with medications that prevent blood clots, improve outcomes in patients who develop atrial fibrillation (irregular heartbeat) after coronary artery bypass grafting surgery.

Who Can Participate?

Eligibility

Adults who developed atrial fibrillation after coronary artery bypass grafting surgery.

What is Involved?

If you agree to be in this study, you will:
- Be randomly assigned (a fair 50/50 chance) to get the study drug or aspirin for 90 days
- Have an in-person study visit at 90 days
- Have blood tests
- Fill out questionnaires
- Have an ECGs (looks at your heart)
- Have phone up to 4 phone calls with a member of the study team

If you do not want to be part of the randomized study you may participate in a registry collecting data from your hospitalization for atrial fibrillation.

Study Details

Full Title

Anticoagulation for the New-Onset Post-Operative Atrial Fibrillation after CABG

Principal Investigator

Brittany
Zwischenberger

Protocol Number

PRO00103761

NCT ID

NCT04045665

Phase

N/A

Enrollment Status

OPEN TO ACCRUAL